Overcoming bioanalytical challenges associated with the separation and quantitation of GSK1278863, a HIF-prolyl hydroxylase inhibitor, and its 14 stereoisomeric metabolites-Reference-Cited by-同舟云学术

Overcoming bioanalytical challenges associated with the separation and quantitation of GSK1278863, a HIF-prolyl hydroxylase inhibitor, and its 14 stereoisomeric metabolites

Published:2016-01 Issue: Volume:1009-1010 Page:7-16
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Licea Perez Hermes,Knecht Dana,Evans Christopher A.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference24 articles.

1. Chronic Hypoxia and Tubulointerstitial Injury: A Final Common Pathway to End-Stage Renal Failure

2. Anemia of end-stage renal disease (ESRD)

3. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency

4. Role of hypoxia in the pathogenesis of renal disease

5. Hypoxia-Inducible Factor 1-Related Diseases and Prospective Therapeutic Tools

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and application of a supercritical fluid chromatography-tandem mass spectrometry method for the simultaneous determination of pantoprazole enantiomers in rat plasma;Journal of Pharmaceutical and Biomedical Analysis Open;2023-12

2. Investigation of the human metabolism and disposition of the prolyl hydrolase inhibitor daprodustat using IV microtracer with Entero‐Test bile string;Pharmacology Research & Perspectives;2023-10-26

3. Supercritical Fluid Chromatography for Chiral Analysis, Part 2: Applications;LCGC Europe;2022-04-01

4. Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic Function;Clinical Pharmacology in Drug Development;2022-03-30

5. A technical overview of supercritical fluid chromatography-mass spectrometry (SFC-MS) and its recent applications in pharmaceutical research and development;Drug Discovery Today: Technologies;2021-12